Anti-Candida albicans activity and brine shrimp lethality test of Hevea brasiiiensis latex B-serum

European Review for Medical and Pharmacological Sciences

Volumn 15, Issue 10, 2011, Pages 1163-1171

  Daruliza, K M A ^a   Yang, K L ^b   Lam, K L ^a   Priscilla, J T ^a   Sunderasan, E ^c   Ong, Ming Thong ^a  

^a INSTITUTE FOR RESEARCH IN MOLECULAR MEDICINE INFORMM   (Malaysia)

^b SCHOOL OF PHYSICS   (Malaysia)

^c RUBBER RESEARCH INSTITUTE OF MALAYSIA   (Malaysia)

Author keywords

Anti fungal; Aspergillus niger; Brine shrimp lethality test; Candida albicans; Hevea brasiliensis; Latex B serum

Indexed keywords

HEVEA BRASILIENSIS EXTRACT; LATEX; LATEX B SERUM; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ARTEMIA; ARTICLE; ASPERGILLUS NIGER; CANDIDA ALBICANS; CONTROLLED STUDY; DISK DIFFUSION; FUNGUS GROWTH; GROWTH INHIBITION; HEVEA BRASILIENSIS; LC 50; LETHALITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; TOXICITY;

ANIMALS; ANTIFUNGAL AGENTS; ARTEMIA; CANDIDA ALBICANS; HEVEA; LATEX; LETHAL DOSE 50; MICROBIAL SENSITIVITY TESTS;

EID: 82455174238     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. DOUGLAS LJ. Candida biofilms and their role in infection. Trends Microbiol 2003; 11: 30-36.
2. EDWARDS JE, Jr. Candida species, p. 2289-2306. In: G.L. Mandell, J.E. Bennett, and R. Dolin (ed.), Mandell, Douglas, and Bennett's Principles and practice of infectious diseases. 4th ed. Churchill Livingstone, Inc., New York, N.Y, 1995.
3. EGGIMANN P, GARBINO J, PITTET D. Epidemiology of Candida species infections in critically ill nonimmunosuppressed patients. Lancet Infect Dis 2003; 3: 685-702.
4. KHAN ZU, CHANDY R, METWALI KE. Candida albicans strain carriage in patients and nursing staff of an intensive care unit: a study of morphotypes and resistotypes. Mycoses 2003; 46: 476-486.
5. KLEPSER ME. Antifungal resistance among Candida species. Pharmacotherapy 2001; 21: 124S-32S.
6. MUSTAFA NK, TANIRA MOM, DAR FK, NSANZE H. Antimicrobial activity of Acacia nilotica sub spp, Nilotica fruit extracts. Pharm Pharmacol Commun 1999; 5: 583-586.
7. RUNYORO DKB, MATEE MIN, NGASSAPA OD, JOSEPH CC, MBWAMBO ZH. Screening of Tanzanian medicinal plants for anti-Candida activity. BMC Com Alternat Med 2006; 30: 6-11.
8. CHOW CK, DRAPER HH. Isolation of gamma-tocotrienol dimers from Hevea latex. Biochemistry 1970; 9: 445-450.
9. BEALING FJ. Quebrachitol synthesis in Hevea brasiliensis. J Rubb Res Inst Malaysia 1981; 29: 111-112.
10. BURTON GW WEBB A, INGOLD KU. A mild, rapid and efficient method of lipid extraction for use in determining vitamin E/ lipid ratios. Lipids 1985; 20: 29-39.
11. WAJANT F, FOSTER S. Purification and characterisation of hydroxyl nitrile lyase from Hevea brasiliensis. Plant Sci 1996; 115; 25-31.
12. DAS G, ALAM B, RAJ S, DEY SK, SETHURAJ MR, SENMANDI S. Over-exploitation associated changes in free radicals and its scavengers in Hevea brasiliensis. J Rubb Res 2002; 5: 28-40.
13. EFFENBERGER F. Hydoxynitrile lyases, interesting biocatalysts in stereo-selective organic syntheses. Int. Conf. Biodiversity and Bioresources: Conservation and Utilisation, Phuket, Thailand 1999; p. 38.
14. ONG MT, YANG KL, LAM KL, ONG GA, SUNDERASAN E. Susceptibility of HeLa (Cancer-origin) Cells to a Sub-fraction of Latex B serum. J Rubb Res 2009; 12: 117-124.
15. MARTIN MN. The latex of Hevea brasiliensis contains high levels of both chitinases and chitinases/lysozymes. Plant Physiol 1991; 95: 469-476.
16. JAN PARUS J, BROEKAERT WF, GOLDSTEIN LJ, PEUMANS WJ. Hevein: an antifungal protein from rubber-tree (Hevea brasiliensis) latex. Planta 1991; 183: 258-264.
17. SUNDERASAN E, SAMSIDAR H, SHARIFAH H, WARD MA, YEANG HY, CARDOSA MJ. Latex B-serum β-1,3-glucanase (Hev b II) and a component of the microhelix (Hev b IV) are major latex allergens. J Nat Rubb Res 1995; 10: 82-99.
18. GIORDANI R, GACHON C, BUC J, REGLI P, JACOB JL. Antifungal action of Hevea brasiliensis latex. Its effect in combination with fluconazole on Candida albicans growth. Mycoses1999; 42: 465-474.
19. JACOP J-L, D'AUZAC J, PREVOT J-C. The composition of natural latex from Hevea brasiliensis. Clin Rev Allergy 1993; 11: 325-337.
20. MOIR GFJ. Ultracentrifugation and staining of Hevea Latex. Nature 1959; 184: 1626.
21. HSIA RCH. Oxygen Absorption by Hevea brasiliensis Latex. Trans Instn Rubb Ind 1958; 34: 267.
22. FINNEY DJ. Probit analysis. 1962 University Press, Cambridge.
23. MEYER BN, FERRIGNI NR. Brine shrimp: a convenient general bioassay for active plant constituents. Planta Med 1982; 45: 31-34.
24. 50 value) in mice, to determine oral acute toxicity of plant extracts. Phytomedicine 2001; 8: 395-400.
25. DANNAOUI E, BOREL E, MONIER MF, PIENS MA, PICOT S, PERSAT F. Acquired itraconazole resistance in Aspergillus fumigatus. J Antimicrob Chemother 2001; 47: 333-340.
26. MARR KA, WHITE TC, VAN BURIK JAH, BOWDEN RA. Development of fluconazole resistance in Candida albicans causing disseminated infection in patient undergoing marrow transplant. Clin Infect Dis 1997; 25: 908-910.
27. GIORDANI R, REGLI P, BUC J. Antifungal effect of Hevea brasiliensis latex with various fungi. Its synergistic action with amphotericin B against Candida albicans. Mycoses 2002; 45: 476-481.
28. YEANG HY, SITI ARIJA MA, FARIDAH Y, SUNDERASAN E. Allergenic proteins of natural rubber latex. Methods 2002; 27: 32-45.
29. BOWMAN SM, FREE SJ. The structure and synthesis of the fungal cell wall. BioEssays 2006; 28: 799-808.
30. MCLAUGHLIN JL, ROGERS LL. The use of biological assays to evaluate botanicals. Drug Inf J 1998; 32: 51.